Pumpkin Protein Powder (Cucurbita pepo)

Pumpkin protein powder (Cucurbita pepo) contains bioactive peptides that demonstrate ACE inhibitory activity, potentially supporting cardiovascular health. Laboratory studies show up to 70.26% ACE inhibition and 77.13% DPP-IV inhibition after simulated digestion.

Category: Other Evidence: 2/10 Tier: Emerging
Pumpkin Protein Powder (Cucurbita pepo) — Hermetica Encyclopedia

Origin & History

Pumpkin protein powder is derived from pumpkin seeds (Cucurbita maxima or Cucurbita pepo) through mechanical pressing to remove oils, followed by drying and milling into powder form. The extraction process may include enzymatic hydrolysis to enhance solubility and bioavailability, with pumpkin seed protein isolate (PSPI) featuring a balanced essential amino acid profile comparable to legume seeds.

Historical & Cultural Context

The research contains no information on traditional medicine use of pumpkin protein powder or pumpkin seeds in any traditional medical system. Historical context and traditional applications are not documented in the provided sources.

Health Benefits

• May support blood pressure regulation through ACE inhibition (up to 70.26% inhibition in vitro studies only)
• Potential glucose metabolism support via DPP-IV inhibition (77.13% inhibition after simulated digestion in laboratory studies)
• Antioxidant activity demonstrated in pepsin hydrolysates (preliminary evidence from in vitro research)
• Antihyperglycemic and antihyperlipidemic activities observed in diabetic rat models (animal evidence only)
• Enhanced protein bioavailability through enzymatic modification (solubility increased from 19.35% to 44.73% in laboratory conditions)

How It Works

Pumpkin protein-derived peptides inhibit angiotensin-converting enzyme (ACE), which normally converts angiotensin I to the vasoconstrictor angiotensin II. The peptides also inhibit dipeptidyl peptidase-IV (DPP-IV), an enzyme that degrades incretin hormones involved in glucose homeostasis. Pepsin hydrolysates demonstrate additional antioxidant activity through free radical scavenging mechanisms.

Scientific Research

No human clinical trials testing pumpkin protein powder as an isolated ingredient were identified in the available research. Evidence is limited to in vitro studies demonstrating ACE and DPP-IV inhibition activities in enzymatic hydrolysates, and animal studies in alloxan-induced diabetic rats showing metabolic benefits. One combination product study (PMCID: PMC6950020) tested whey protein with pumpkin pectin in hypertensive rats, but this did not isolate pumpkin protein effects.

Clinical Summary

Current evidence for pumpkin protein powder is limited to in vitro laboratory studies and simulated digestion models. Studies show ACE inhibition up to 70.26% and DPP-IV inhibition of 77.13% in laboratory conditions. No human clinical trials have been conducted to validate cardiovascular or metabolic benefits. The antioxidant activity has only been demonstrated in pepsin hydrolysate preparations under controlled laboratory conditions.

Nutritional Profile

Pumpkin protein powder (Cucurbita pepo) is a high-protein concentrate typically containing 60–70% protein by dry weight, with a relatively complete amino acid profile including glutamic acid (~18–20% of total amino acids), aspartic acid (~10–12%), arginine (~8–10%), leucine (~6–8%), and lysine (~5–6%). Fat content is generally low at 1–5%, predominantly unsaturated fatty acids (linoleic and oleic acids). Carbohydrate content ranges from 10–20%, with residual dietary fiber at approximately 3–8%. Ash/mineral content sits at roughly 5–8% dry weight, providing meaningful quantities of magnesium (~300–500 mg/100g), phosphorus (~700–900 mg/100g), potassium (~600–800 mg/100g), iron (~8–15 mg/100g), zinc (~6–10 mg/100g), and copper (~1–2 mg/100g). Bioactive compounds include cucurbitin (a unique cyclic amino acid), tocopherols (primarily gamma-tocopherol, ~10–30 mg/100g in whole seed but reduced in isolates), and phenolic compounds including ferulic and p-coumaric acids at trace concentrations. Bioavailability note: protein digestibility is moderate to good (PDCAAS estimated 0.6–0.8 range); digestive hydrolysis (pepsin/pancreatin) significantly enhances bioactive peptide release, particularly ACE-inhibitory and DPP-IV-inhibitory peptides, meaning bioactive potential increases substantially post-digestion. Antinutritional factors such as phytic acid (~1–3% in raw seed) are partially reduced during processing into protein powder, improving mineral bioavailability compared to whole seed.

Preparation & Dosage

No clinically studied dosage ranges for pumpkin protein powder in humans are available in the research. Laboratory studies report enzyme-to-substrate ratios of 1:100 for protein modification and 3% enzyme/substrate ratios for peptide production, but these are processing parameters, not human dosing recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Whey protein hydrolysate, Pumpkin pectin, Egg-white protein, Plant-based protein blends, Digestive enzymes

Safety & Interactions

Pumpkin protein powder appears generally safe for most individuals as it derives from common food sources. However, individuals with pumpkin or cucurbit allergies should avoid this supplement. No specific drug interactions have been documented, though theoretical interactions may occur with ACE inhibitor medications due to similar mechanisms. Safety during pregnancy and lactation has not been established through clinical studies.